Renate Margreiter

Title: Renate Margreiter: Innovator in Pharmaceutical Science

Introduction

Renate Margreiter is a notable inventor based in Kundl, Austria. She has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative drug formulations. Her work focuses on improving the efficacy and safety of medications for patients with chronic health conditions.

Latest Patents

Renate Margreiter holds a patent for a co-crystal of an orally available HIF prolyl hydroxylase inhibitor. This invention relates to a co-crystal of roxadustat with L-proline and outlines a process for its preparation. The pharmaceutical composition derived from this co-crystal can be utilized as a medicament, specifically for the treatment and prevention of anemia in patients suffering from end-stage renal disease (ESRD) and chronic kidney disease (CKD). She has 1 patent to her name.

Career Highlights

Throughout her career, Renate has worked with prominent companies in the pharmaceutical industry, including Sandoz AG. Her expertise in drug formulation and development has positioned her as a valuable asset in the field.

Collaborations

Renate has collaborated with esteemed colleagues such as Hannes Lengauer and Arthur Pichler. These partnerships have further enhanced her research and development efforts in pharmaceutical innovations.

Conclusion

Renate Margreiter's contributions to pharmaceutical science exemplify her dedication to improving patient care through innovative drug formulations. Her work continues to impact the treatment of chronic diseases, showcasing the importance of research and development in healthcare.